[On the pharmacology and toxicology of the spasmolytic beta-diethyl-aminoethyl-(alpha-methyl-2,5-endomethylene-delta3-tetrahydrobenzhydryl)-ether-bromethylate].
D000014:Abnormalities, Drug-Induced; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004285:Dogs; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D006168:Guinea Pigs; D007412:Intestinal Fistula; D007421:Intestine, Small / Q000187:drug effects; D008297:Male; D051379:Mice; D009132:Muscles / Q000494:pharmacology* / Q000633:toxicity*; D009184:Mydriatics / Q000494:pharmacology; D010115:Oxyphenonium / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D011247:Pregnancy; D011674:Pulse / Q000187:drug effects; D011680:Pupil / Q000187:drug effects; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D051381:Rats; D013276:Stomach Ulcer / Q000517:prevention & control
D009184:Mydriatics; D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds; D010115:Oxyphenonium
Zur Pharmakologie und Toxikologie des Spasmolyticums beta-Diäthyl-aminoäthyl-(alpha-methyl-2,5-endomethylen-delta3-tetrahydrobenzhydryl)-äther-brommethylat.